Direct and Indirect Effects of Upadacitinib or Adalimumab on Pain in Rheumatoid Arthritis: Results from a Randomized Phase 3 Study

被引：0

作者：

Taylor, Peter C. ^{[1
]}

Walsh, David ^{[2
]}

Takeuchi, Tsutomu ^{[3
,4
]}

Fautrel, Bruno ^{[5
]}

Pope, Janet ^{[6
]}

Garrison, Andrew ^{[7
]}

Song, Yanna ^{[7
]}

Penn, Sara K. ^{[7
]}

Lippe, Ralph ^{[8
]}

Caballero, Diane ^{[9
]}

Kavanaugh, Arthur ^{[10
]}

机构：

[1] Univ Oxford, Nuffield Dept Orthoped Rheumatol & Musculoskeleta, Oxford, England

[2] Univ Nottingham, Nottingham, England

[3] Keio Univ, Sch Med, Tokyo, Japan

[4] Saitama Med Univ, Tokyo, Japan

[5] Sorbonne Univ, APHP, Paris, France

[6] Univ Western Ontario, London, ON, Canada

[7] AbbVie Inc, N Chicago, IL USA

[8] AbbVie Deutschland GmbH & Co KG, Wiesbaden, Germany

[9] AbbVie Inc, Chicago, IL USA

[10] Univ Calif San Diego, Sch Med, Riverside, CA USA

来源：

ARTHRITIS & RHEUMATOLOGY | 2023年 / 75卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

0429

引用

页码：831 / 833

页数：3

共 50 条

[1] Direct and Indirect Effects of Upadacitinib or Adalimumab on Pain in Psoriatic Arthritis: Results from a Randomized Phase 3 Study
Taylor, Peter C.
Walsh, David
Takeuchi, Tsutomu
Fautrel, Bruno
Pope, Janet
Kato, Koji
Setty, Arathi
Gao, Tianming
Caballero, Diane
Lippe, Ralph
Kavanaugh, Arthur
ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 4457 - 4459
[2] A Phase 3, Randomized, Double-Blind Study Comparing Upadacitinib to Placebo and to Adalimumab, in Patients with Active Rheumatoid Arthritis with Inadequate Response to Methotrexate
Fleischmann, Roy
Pangan, Aileen L.
Mysler, Eduardo
Bessette, Louis
Peterfy, Charles
Durez, Patrick
Ostor, Andrew
Li, Yihan
Zhou, Yijie
Othman, Ahmed A.
Song, In-Ho
Genovese, Mark C.
ARTHRITIS & RHEUMATOLOGY, 2018, 70
[3] Safety and Effectiveness of Upadacitinib or Adalimumab in Patients with Rheumatoid Arthritis: Results at 48 Weeks
Fleischmann, Roy
Enejosa, Jose Jeffrey
Song, In-Ho
Mysler, Eduardo
Bessette, Louis
Peterfy, Charles
Durez, Patrick
Ostor, Andrew
Zhou, Yijie
Genovese, Mark
ARTHRITIS & RHEUMATOLOGY, 2019, 71
[4] SAFETY AND EFFECTIVENESS OF UPADACITINIB OR ADALIMUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS AT 48 WEEKS FROM THE SELECT-COMPARE STUDY
Fleischmann, Roy
Enejosa, Jeffrey
Song, In-Ho
Mysler, Eduardo
Bessette, Louis
Peterfy, Charles
Durez, Patrick
Ostor, Andrew
Li Yihan
Zhou, Yijie
Genovese, Mark C.
ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 744 - 745
[5] LONG-TERM SAFETY AND EFFICACY OF UPADACITINIB OR ADALIMUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS AT 3 YEARS FROM THE SELECT-COMPARE STUDY
Fleischmann, R.
Mysler, E.
Bessette, L.
Peterfy, C.
Durez, P.
Tanaka, Y.
Swierkot, J.
Khan, N.
Bu, X.
Li, Y.
Song, I. H.
ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 251 - 252
[6] Long-Term Safety and Efficacy of Upadacitinib or Adalimumab in Patients with Rheumatoid Arthritis: Results at 3 Years from the SELECT-COMPARE Study
Fleischmann, Roy
Mysler, Eduardo
Bessette, Louis
Peterfy, Charles
Durez, Patrick
Tanaka, Yoshiya
Swierkot, Jerzy
Khan, Nasser
Bu, Xianwei
Li, Yihan
Song, In-Ho
ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 1708 - 1710
[7] Upadacitinib Versus Placebo or Adalimumab in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate: Results of a Phase III, Double-Blind, Randomized Controlled Trial
Fleischmann, Roy
Pangan, Aileen L.
Song, In-Ho
Mysler, Eduardo
Bessette, Louis
Peterfy, Charles
Durez, Patrick
Ostor, AndrewJ
Li, Yihan
Zhou, Yijie
Othman, Ahmed A.
Genovese, Mark C.
ARTHRITIS & RHEUMATOLOGY, 2019, 71 (11) : 1788 - 1800
[8] Long-term safety and efficacy of upadacitinib or adalimumab in patients with rheumatoid arthritis: results through 3 years from the SELECT-COMPARE study
Fleischmann, Roy
Mysler, Eduardo
Bessette, Louis
Peterfy, Charles G.
Durez, Patrick
Tanaka, Yoshiya
Swierkot, Jerzy
Khan, Nasser
Bu, Xianwei
Li, Yihan
Song, In-Ho
RMD OPEN, 2022, 8 (01):
[9] SUSTAINABILITY OF RESPONSE BETWEEN UPADACITINIB AND ADALIMUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS THROUGH 3 YEARS FROM THE SELECT-COMPARE TRIAL
Nash, P.
Kavanaugh, A.
Buch, M. H.
Combe, B.
Bessette, L.
Song, I. H.
Shaw, T.
Song, Y.
Suboticki, J.
Fleischmann, R. M.
ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 591 - 592
[10] Sustainability of Response Between Upadacitinib and Adalimumab in Patients With Rheumatoid Arthritis: Results Through 3 Years from the SELECT-COMPARE Trial
Nash, Peter
Kavanaugh, Arthur
Buch, Maya
Combe, Bernard
Bessette, Louis
Song, In-Ho
Shaw, Tim
Song, Yanna
Suboticki, Jessica
Fleischmann, Roy
JOURNAL OF RHEUMATOLOGY, 2022, 49 (07) : 775 - 776

← 1 2 3 4 5 →